Hjem › Plateepitelcancer i hode og hals › Texas › Dallas
Kliniske studier for Plateepitelcancer i hode og hals i Dallas, TX
20 studier for Plateepitelcancer i hode og hals søker deltakere på steder i og rundt Dallas (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RekruttererFase 1
- Exelixis Clinical Site #89, Dallas
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
RekruttererFase 3
- UT Southwestern Medical Center, Dallas
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
RekruttererFase 1/2
- Baylor, Scott and White Research Institute, Dallas
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
RekruttererObservasjonsstudie
- UT Southwestern Medical Center, Dallas
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
RekruttererFase 1
- Normunity Investigational Site, Dallas
A Study of DM005 in Patients With Advanced Solid Tumors
RekruttererFase 1/2
- Sarah Cannon Research Institute at Mary Crowley, Dallas
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
RekruttererFase 1/2
- Texas Oncology, P.A., Dallas
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
RekruttererFase 1/2
- Texas Oncology, Dallas
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
RekruttererFase 1
- University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
- UT Southwestern Medical Center - Redbird, Dallas
- Univ. of TX Southwestern Medical Center - Zale Lipshy University Hospital, Dallas
- og 2 flere
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
RekruttererFase 1/2
- Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas
- University of Texas Southwestern, Dallas
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
RekruttererFase 1
- University of Texas Southwestern Medical Center /ID# 251974, Dallas
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
RekruttererFase 3
- GSK Investigational Site, Dallas
A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)
RekruttererFase 2
- University of Texas Southwestern Medical Center, Dallas
A Study of VET3-TGI in Patients With Solid Tumors
RekruttererFase 1
- Mary Crowley Cancer Research, Dallas
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- NEXT Oncology - Dallas, Dallas
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
RekruttererFase 1
- Mary Crowley Cancer Research, Dallas
- Baylor University Medical Center, Dallas
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
RekruttererFase 1
- Dren Investigational Site, Dallas
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
RekruttererFase 1/2
- Research Site 120, Dallas
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- Mary Crowley Cancer Research, Dallas
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
RekruttererFase 1/2
- Mary Crowley Cancer Research, Dallas
- University of Texas Southwestern Medical Center, Dallas
Plateepitelcancer i hode og hals-studier i andre byer
- Houston, TX47 studier
- Los Angeles, CA42 studier
- Boston, MA40 studier
- New York City, NY39 studier
- Nashville, TN39 studier
- St. Louis, MO28 studier
- Arlington, VA26 studier
- Philadelphia, PA26 studier
- Chicago, IL26 studier
- Atlanta, GA24 studier
- San Antonio, TX22 studier
- New Haven, CT22 studier
Andre studier i Dallas
- Brystkreft55 studier
- Ikke-småcellet lungekreft52 studier
- Metastatisk kreft42 studier
- Hjertesvikt42 studier
- Kreft (alle typer)37 studier
- Prostatakreft36 studier
- Kolorektal kreft33 studier
- Fedme30 studier
- Eggstokkreft28 studier
- Lungekreft27 studier
- Blærekreft27 studier
- Endometriekreft24 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.